Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Wisdom of experience or faculty of reason: Ischemic mitral regurgitation trials-Cardiothoracic Surgical Trials Network and beyond.

JTCVS open·2022

Same author

Long-term results of surgical ventricular reconstruction and comparison with the Surgical Treatment for Ischemic Heart Failure trial.

The Journal of thoracic and cardiovascular surgery·2022

Same author

Cost-Effectiveness of Coronary Artery Bypass Surgery Versus Medicine in Ischemic Cardiomyopathy: The STICH Randomized Clinical Trial.

Circulation·2022

Same author

Restoring ventricular restoration: A call to re-evaluate a surgical therapy considered ineffective.

Journal of cardiac surgery·2021

Same author

De Novo Renal Failure and Clinical Outcomes of Patients With Critical Coronavirus Disease 2019.

Critical care medicine·2020

Same author

The role of stem cells in treating coronary artery disease in 2018.

Indian journal of thoracic and cardiovascular surgery·2020

Same journal

Beta-Blockers Versus Flecainide for Atrial Fibrillation: A First-Line Strategy Review of Efficacy, Safety, and Patient Selection.

Cardiology in review·2026

Same journal

Cerebrovascular Disease in Pregnancy: Epidemiology, Pathophysiology, Risk Factors, Diagnostic and Management Considerations, Long-Term Maternal Outcomes: A Narrative Review.

Cardiology in review·2026

Same journal

Immunometabolism in Cardiovascular Disease: Linking Metabolic Reprogramming to Inflammation, Atherothrombosis, and Clinical Outcomes.

Cardiology in review·2026

Same journal

Cardiotoxicity of Antibody-Drug Conjugates in HER2-Positive Cancer: Beyond Left Ventricular Ejection Fraction Decline.

Cardiology in review·2026

Same journal

Celiac Disease and Cardiovascular Disease: Epidemiology, Mechanisms, and Clinical Challenges.

Cardiology in review·2026

Same journal

Valve-Specific Comparative Effectiveness of Direct Oral Anticoagulants Versus Vitamin K Antagonists After Surgical Valve Procedures in Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Cardiology in review·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 2, 2026

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

Stem cell therapy for heart failure.

Robert E Michler¹

¹From the Departments of Surgery and Cardiovascular & Thoracic Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY.

Cardiology in Review

|March 6, 2014

Summary

This summary is machine-generated.

First-generation stem cell therapy using bone marrow cells is safe and modestly effective. Current research suggests paracrine effects, not transdifferentiation, drive these benefits, guiding future cardiac stem cell trials.

More Related Videos

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Related Experiment Videos

Last Updated: May 2, 2026

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Area of Science:

Regenerative Medicine
Cardiovascular Research
Stem Cell Biology

Background:

Extensive clinical trials over the past decade have utilized bone marrow-derived stem cells for therapeutic interventions.
These initial trials provided valuable insights into the safety and efficacy of cell-based therapies.

Purpose of the Study:

To review the findings from first-generation stem cell clinical trials.
To elucidate the primary mechanisms of action for stem cell therapy in cardiac applications.
To identify future directions for stem cell research in cardiovascular regeneration.

Main Methods:

Review of published clinical trial data focusing on bone marrow-derived stem cells.
Analysis of proposed mechanisms of action for cell therapy.
Identification of emerging trends in stem cell research for cardiac regeneration.

Main Results:

Cell therapy is established as safe.
Modest therapeutic effectiveness has been observed.
Bone marrow-derived stem cells do not significantly transdifferentiate into cardiomyocytes or vascular structures in humans.
The predominant mechanism involves paracrine signaling, releasing factors that reduce apoptosis and fibrosis, improve contractility, and stimulate endogenous repair.

Conclusions:

Stem cell therapy, particularly using bone marrow-derived cells, has demonstrated safety and moderate efficacy.
Paracrine mechanisms are now considered the primary drivers of therapeutic benefits.
Future clinical trials are shifting towards stem cells with inherent cardiac lineage potential, such as endogenous cardiac stem cells.